StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$6.08−0.16 (-2.56%)

Close on Nov 13, 2026Market cap $41.23MP/E –Yield –

Instil Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Instil Bio's price to book ratio was 0.4× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 3.7×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.2
2025Dec 31, 20250.6×−0.1
2024Dec 31, 20240.7×+0.5
2023Dec 29, 20230.2×+0.0
2022Dec 30, 20220.2×−3.5
2021Dec 31, 20213.7×–

More Instil Bio figures

See a number that looks wrong?